- Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
- Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
- Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
- Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference
More ▼
Key statistics
On Friday, Astria Therapeutics Inc (ATXS:NMQ) closed at 9.00, 111.27% above the 52 week low of 4.26 set on Nov 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.18 |
---|---|
High | 9.46 |
Low | 8.97 |
Bid | 8.06 |
Offer | 9.21 |
Previous close | 9.17 |
Average volume | 843.93k |
---|---|
Shares outstanding | 54.90m |
Free float | 48.15m |
P/E (TTM) | -- |
Market cap | 494.13m USD |
EPS (TTM) | -2.34 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼